Insider Trading activities of Chromavision Medical Systems Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chromavision Medical Systems Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chromavision Medical Systems Inc since year 2005. Table 2 shows the detailed insider transactions of Chromavision Medical Systems Inc since 2005. The reporting company's ticker symbol is CLRT. The reporting company's CIK number is 1038223.
The total value of stock buying since 2005 is $13,088,612.
The total value of stock sales since 2005 is $64,642,124.
The total value of stock option exercises since 2005 is $73,600.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Chromavision Medical Systems Inc (CLRT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-06 0 $0 1,600 $4,736 0 $0
2010-05 0 $0 1,810 $5,737 0 $0
2010-04 0 $0 1,575 $4,189 0 $0
2010-03 111,359 $269,981 2,100 $4,116 0 $0
2010-02 0 $0 1,950 $4,309 0 $0
2010-01 0 $0 1,850 $5,032 0 $0
2009-12 0 $0 1,750 $4,252 0 $0
2009-11 0 $0 1,675 $5,175 0 $0
2009-10 0 $0 1,540 $6,391 0 $0
2009-09 0 $0 2,401,525 $8,406,176 0 $0
2009-08 0 $0 16,001,616 $56,006,051 0 $0
2009-07 0 $0 26,700 $88,110 0 $0
2008-12 59,400 $97,015 0 $0 0 $0
2008-11 88,000 $80,970 0 $0 0 $0
2008-09 54,500 $104,751 0 $0 0 $0
2008-08 15,500 $33,092 0 $0 0 $0
2008-06 50,000 $100,950 0 $0 0 $0
2008-05 15,000 $30,400 0 $0 0 $0
2007-05 50,500 $103,550 0 $0 0 $0
2007-03 35,000 $60,700 50,000 $97,850 69,000 $73,600
2006-09 4,162,042 $3,000,832 0 $0 0 $0
2005-11 9,114,300 $9,133,472 0 $0 0 $0
2005-06 51,600 $72,899 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Chromavision Medical Systems Inc insiders (CLRT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-06-01 Daly David (Sr. VP of Commercial Ops) Sale 1,600 2.96 4,736
2010-05-03 Daly David (Sr. VP of Commercial Ops) Sale 1,810 3.17 5,737
2010-04-05 Daly David (Sr. VP of Commercial Ops) Sale 1,575 2.66 4,189
2010-03-15 Smith Dennis M Jr Buy 50,000 2.44 121,750
2010-03-15 Slattery Frank P Jr Buy 10,000 2.44 24,400
2010-03-12 Smith Dennis M Jr Buy 30,000 2.42 72,450
2010-03-12 Andrews Ronald Asbury (Vice-Chairman and CEO) Buy 12,000 2.41 28,920
2010-03-12 Slattery Frank P Jr Buy 9,359 2.40 22,461
2010-03-01 Daly David (Sr. VP of Commercial Ops) Sale 2,100 1.96 4,116
2010-02-04 Daly David (Sr. VP of Commercial Ops) Sale 1,950 2.21 4,309
2010-01-05 Daly David (Sr. VP of Commercial Ops) Sale 1,850 2.72 5,032
2009-12-02 Daly David (Sr. VP of Commercial Ops) Sale 1,750 2.43 4,252
2009-11-03 Daly David (Sr. VP of Commercial Ops) Sale 1,675 3.09 5,175
2009-10-05 Daly David (Sr. VP of Commercial Ops) Sale 1,540 4.15 6,391
2009-09-18 Safeguard Scientifics Inc (10% Owner) Sale 2,400,000 3.50 8,400,000
2009-09-03 Daly David (Sr. VP of Commercial Ops) Sale 1,525 4.05 6,176
2009-08-27 Safeguard Scientifics Inc (10% Owner) Sale 16,000,000 3.50 56,000,000
2009-08-06 Daly David (Sr. VP of Commercial Ops) Sale 1,616 3.74 6,051
2009-07-13 Daly David (Sr. VP of Commercial Ops) Sale 26,700 3.30 88,110
2008-12-16 Smith Dennis M Jr Buy 49,400 1.63 80,815
2008-11-25 Pellini Michael J (President and COO) Buy 8,000 1.03 8,240
2008-11-24 Land Raymond J (Sr. VP and CFO) Buy 10,000 .93 9,310
2008-11-21 Smith Dennis M Jr Buy 70,000 .91 63,420
2008-09-18 Andrews Ronald Asbury (President and CEO) Buy 7,500 1.93 14,505
2008-09-18 Land Raymond J (Senior V.P. & CFO) Buy 5,000 1.90 9,520
2008-09-17 Smith Dennis M Jr (Director) Buy 10,000 1.74 17,390
2008-09-16 Pellini Michael J (President & COO) Buy 3,500 1.90 6,650
2008-09-15 Smith Dennis M Jr (Director) Buy 18,000 1.97 35,442
2008-09-12 Pellini Michael J (President & COO) Buy 3,500 2.09 7,314
2008-09-11 Smith Dennis M Jr (Director) Buy 7,000 1.99 13,930
2008-08-12 Land Raymond J (Senior V.P. & CFO) Buy 15,500 2.14 33,092
2008-06-05 Smith Dennis M Jr (Director) Buy 25,000 2.04 51,100
2008-06-04 Smith Dennis M Jr (Director) Buy 25,000 1.99 49,850
2008-05-30 Pellini Michael J (President & COO) Buy 5,000 2.00 10,000
2008-05-30 Wampler Jon R (Director) Buy 10,000 2.04 20,400
2007-05-09 Smith Dennis M Jr Buy 5,000 2.32 11,600
2007-05-09 Torrebueno Jose De La (VP, Chief Tech Officer) Buy 1,000 2.36 2,360
2007-05-07 Smith Dennis M Jr Buy 20,000 2.06 41,100
2007-05-07 Andrews Ronald Asbury (President and CEO) Buy 5,000 1.92 9,600
2007-05-07 Agnello James V (Sr. VP and CFO) Buy 5,000 2.06 10,325
2007-05-07 Slattery Frank P Jr Buy 14,500 1.97 28,565
2007-03-20 Wampler Jon R (Director) Option Ex 19,000 .95 18,050
2007-03-16 Creran Heather (EVP & COO, Diagnostic Services) Sale 50,000 1.96 97,850
2007-03-16 Creran Heather (EVP & COO, Diagnostic Services) Option Ex 50,000 1.11 55,550
2007-03-13 Slattery Frank P Jr (Director) Buy 10,000 1.72 17,200
2007-03-12 Slattery Frank P Jr (Director) Buy 25,000 1.74 43,500
2006-09-22 Safeguard Scientifics Inc (10% Owner) Buy 4,162,042 .72 3,000,832
2005-11-14 Andrews Ronald Asbury (President and CEO) Buy 10,000 1.19 11,880
2005-11-14 Scher Irwin (Director) Buy 20,000 1.20 23,900
2005-11-11 Slattery Frank P Jr (Director) Buy 50,000 1.16 57,998
2005-11-11 Dixon Stephen T D (&) Buy 9,300 1.15 10,695
2005-11-08 Safeguard Scientifics Inc (10% Owner) Buy 9,000,000 1.00 9,000,000
2005-06-14 Hamm Steve (Director) Buy 6,500 1.49 9,704
2005-06-14 Scher Irwin (Director) Buy 6,000 1.50 9,000
2005-06-14 Torrebueno Jose De La (V.P., Chief Technolo) Buy 1,000 1.52 1,516
2005-06-13 Slattery Frank P Jr (Director) Buy 11,600 1.38 15,950
2005-06-10 Andrews Ronald Asbury (President and CEO) Buy 18,000 1.40 25,254
2005-06-10 Slattery Frank P Jr (Director) Buy 8,500 1.35 11,475

Insider trading activities including stock purchases, stock sales, and option exercises of CLRT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chromavision Medical Systems Inc (symbol CLRT, CIK number 1038223) see the Securities and Exchange Commission (SEC) website.